Scholars Central

Review articlePublished 2014

The Role of Adjuvant Radiation in High Risk Early-Stage Endometrial Cancer

Authors: Sareena Singh, Amy Armstrong, Analisa DiFeo

Nuclear Medicine & Radiation Therapy

Volume 5 · Issue 3 · Pages 1–4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Endometrial cancer is the most commonly diagnosed malignancy of the female genital tract in the United States. The role of adjuvant radiation for the treatment of patients with early stage disease is still heavily debated, as no overall survival benefit has been demonstrated in large prospective trials. There is, however, evidence to suggest a decrease in recurrence risk with administration of adjuvant radiotherapy, especially in patients with high-risk features. In this review, we describe the relevant literature to date, define how we determine which patients are considered high or intermediate risk, and describe the findings related to the addition of chemotherapy to adjuvant brachytherapy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Nuclear Medicine & Radiation Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalNuclear Medicine & Radiation Therapy
  • SubjectRadiology & Imaging
  • SubjectEnergy & Power
  • BylineArticles whose byline prints “Sareena Singh”
  • BylineArticles whose byline prints “Amy Armstrong”
  • BylineArticles whose byline prints “Analisa DiFeo”